WebFind the latest Shuttle Pharmaceuticals Holdings, Inc. (SHPH) stock quote, history, news and other vital information to help you with your stock trading and investing.
Did you know?
Web2 days ago · Shuttle Pharmaceuticals Holdings, Inc., through its subsidiary, Shuttle Pharmaceuticals, Inc., focuses on the discovery, development, and commercialization of drugs for sensitizing cancers to radiation therapy. Its products in clinical stage include Ropidoxuridine, an oral halogenated pyrimidine to treat patients with brain tumors and … WebGet Shuttle Pharmaceuticals Holdings Inc (SHPH:NASDAQ) real-time stock quotes, news, price and financial information from CNBC.
WebDiscover historical prices for SHPH stock on Yahoo Finance. View daily, weekly or monthly format back to when Shuttle Pharmaceuticals Holdings, Inc. stock was issued. WebShuttle Pharmaceuticals Holdings Inc is a clinical stage pharmaceutical company leveraging our proprietary technology to develop novel therapies designed to cure cancers. ... Stock prices can fluctuate wildly, and analyst ratings are provided to help self-directed traders evaluate securities.
Web1 day ago · Price To Free Cash Flow is a widely used stock evaluation measure. Find the latest Price To Free Cash Flow for Shuttle Pharmaceuticals Holdings, Inc. (SHPH) WebShuttle Pharmaceuticals Provides Fiscal Year 2024 Corporate Update. Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH), a discovery and development stage specialty pharmaceutical company ...
WebShuttle Pharmaceuticals Holdings Inc is a clinical stage pharmaceutical company leveraging our proprietary technology to develop novel therapies designed to cure cancers. The company's goal is to extend the benefits of cancer treatments by leveraging insights into the pillars of cancer therapy: surgery, radiation therapy, chemotherapy, and ...
WebMar 31, 2024 · On Thursday morning 04/13/2024 the Shuttle Pharmaceuticals Holdings Inc Registered Shs share started trading at the price of $1.28. Compared to the closing price on Wednesday 04/12/2024 on NAS of ... earning points from flightsWebShuttle Pharmaceuticals Provides Fiscal Year 2024 Corporate Update. Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH), a discovery and development stage specialty pharmaceutical company focused on improving outcomes for cancer patients treated with radiation therapy (RT), today provided a corporate update in connection with … earning reportsWebMar 3, 2024 · Shuttle Pharmaceuticals Holdings, Inc., through its subsidiary, Shuttle Pharmaceuticals, Inc., focuses on the discovery, development, and commercialization of drugs for sensitizing cancers to radiation therapy. earning reports today google timeWebMar 30, 2024 · Shuttle Pharmaceuticals Holdings, Inc. (SHPH) has a Smart Score of N/A based on an analysis of 8 unique data sets, including Analyst Recommendations, ... Shuttle Pharmaceuticals Holdings, Inc. lowest stock price was $1.18 and its highest was $126.26 in the past 12 months. earning records for social securityWebAug-30-22 04:40PM. Shuttle Pharmaceuticals Announces Pricing of Initial Public Offering. PR Newswire. Shuttle Pharmaceuticals Holdings, Inc., through its subsidiary, Shuttle Pharmaceuticals, Inc., focuses on the discovery, development, and commercialization of drugs for sensitizing cancers to radiation therapy. earning reports this weekWebSep 6, 2024 · PR Newswire. ROCKVILLE, Md., Sept. 6, 2024 /PRNewswire/ -- Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH), a discovery and development stage specialty pharmaceutical company focused on ... earning reports todayWebMar 17, 2024 · Shuttle Pharmaceuticals Holdings, Inc., through its subsidiary, Shuttle Pharmaceuticals, Inc., focuses on the discovery, development, and commercialization of drugs for sensitizing cancers to radiation therapy. Its products in clinical stage include Ropidoxuridine, an oral halogenated pyrimidine to treat patients with brain tumors and … cswip paut